Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
Nosocomial Infection, Bacteremia, Sepsis
About this trial
This is an interventional prevention trial for Nosocomial Infection focused on measuring Chlorhexidine, Blood stream infections, central venous catheter associated, Nosocomial infection, Bacteremia, sepsis, Pneumonia, Urinary tract infection, Clostridium Difficile, intensive care unit, catheter, nosocomial pneumonia, Infection control
Eligibility Criteria
Inclusion Criteria: Data collection will be compiled from all the participants admitted to the Medical Intensive Care Unit (MICU). For skin cultures: One randomly selected (intubated or non-intubated) patient in each intervention group Exclusion Criteria: Patients with greater than 20% of body surface area disruption in skin integrity will be excluded from participation in the 2% CHG Antiseptic Cloths arm of the study
Sites / Locations
- John H. Stroger Hospital of Cook County
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
chlorhexidine gluconate (CHG)
Soap & Water
daily skin cleansing with no-rinse, 2% CHG-impregnated cloths (Sage)
bathing daily with bar soap (Dial Corp., Scottsdale, AZ) warm water, and cotton washcloths